Breast cancer, early breast cancer, locally advance breast cancer Breast cancer, Sentinel lymph node biopsy, Targeted axillary dissection, Axillary lymph node dissection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: all women aged more than 18 years with pathologically confirmed invasive breast cancer with early stage cT1-2N0-1 M0 and suspicious nodes detected by ultrasonography or mammography with surgery upfront or breast cancer stage cT1-4N2M0, cT3-4N1M0, or cT1-2N0-1M0 who received neoadjuvant systemic treatment with suspicious nodes detected by ultrasonography or mammography and underwent surgery in the Breast and Endocrine Unit, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand, between January 2021 and December 2022
Exclusion criteria
Exclusion criteria: prior cancer, ineligibility for FNA or CNB of the axilla, or allergies to nickel or titanium
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| whether a suspicious node was a sentinel node by correlating the suspected axillary lymph nodes at 2 months after end of the intervention Intra operative finding of clip suspicious node in sentinel node (Number, percent) | — |
Secondary
| Measure | Time frame |
|---|---|
| accuracy of FNA of suspicious nodes at 2 months after end of the intervention Compare number of intra operative finding of clip suspicious node in sentinel node (Number, percent),Loss clip at 2 months after end of the intervention Number of operation that cannot identified clip in specimen (Number, percent) | — |
Countries
Thailand
Contacts
Faculty of Medicine Ramathibodi Hospital